Trial
NCT02908516
Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Hip Fractures
Intervention
Tranexamic Acid
Why stopped
Study was terminated due to inability to recruit and collect follow up outcome data.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-07-29